Tumor lysis syndrome differential diagnosis: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
Line 3: Line 3:
{{CMG}} {{AE}} {{MJK}}
{{CMG}} {{AE}} {{MJK}}
==Overview==
==Overview==
Tumor lysis syndrome must be differentiated from other diseases that cause [[hyperuricemia]], [[hyperkalemia]], and [[hyperphosphatemia]], such as [[acute kidney injury]].<ref name="pmid24359983">{{cite journal| author=Wilson FP, Berns JS| title=Tumor lysis syndrome: new challenges and recent advances. | journal=Adv Chronic Kidney Dis | year= 2014 | volume= 21 | issue= 1 | pages= 18-26 | pmid=24359983 | doi=10.1053/j.ackd.2013.07.001 | pmc=PMC4017246 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24359983  }} </ref>
Tumor lysis syndrome must be differentiated from other diseases that cause [[hyperuricemia]], [[hyperkalemia]], and [[hyperphosphatemia]], such as [[acute kidney injury]]. The common conditions are hereditary hyperuricemia, [[Insulin resistance]], [[Hypertension]], [[Obesity]], [[Gout]], [[Alcoholism]] and [[renal insufficiency]]. Patients taking [[ACE inhibitor]], [[Non-steroidal anti-inflammatory drugs|NSAIDs]]  and [[Antibiotics]] such as [[trimethoprim]] are more prone to hyperkalemia. [[Hyperphosphatemia]] is usually seen in [[Acute kidney injury]], [[Hypoparathyroidism]], [[Hypervitaminosis D|vitamin D]] supplementation and also in [[Sarcoidosis|sarcoidos]].
 
==Differentiating tumor lysis syndrome from other Diseases==
==Differentiating tumor lysis syndrome from other Diseases==
Tumor lysis syndrome must be differentiated from other diseases that cause electrolytes disturbance.<ref name="pmid24359983">{{cite journal| author=Wilson FP, Berns JS| title=Tumor lysis syndrome: new challenges and recent advances. | journal=Adv Chronic Kidney Dis | year= 2014 | volume= 21 | issue= 1 | pages= 18-26 | pmid=24359983 | doi=10.1053/j.ackd.2013.07.001 | pmc=PMC4017246 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24359983  }} </ref>
Tumor lysis syndrome must be differentiated from other diseases that cause electrolytes disturbance.<ref name="pmid24359983">{{cite journal| author=Wilson FP, Berns JS| title=Tumor lysis syndrome: new challenges and recent advances. | journal=Adv Chronic Kidney Dis | year= 2014 | volume= 21 | issue= 1 | pages= 18-26 | pmid=24359983 | doi=10.1053/j.ackd.2013.07.001 | pmc=PMC4017246 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24359983  }} </ref>
Line 65: Line 66:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
   
   
[[Category:Disease]]
[[Category:Disease]]

Revision as of 20:04, 6 September 2018

Tumor lysis syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tumor lysis syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tumor lysis syndrome differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tumor lysis syndrome differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tumor lysis syndrome differential diagnosis

CDC on Tumor lysis syndrome differential diagnosis

Tumor lysis syndrome differential diagnosis in the news

Blogs on Tumor lysis syndrome differential diagnosis

Directions to Hospitals Treating Tumor lysis syndrome

Risk calculators and risk factors for Tumor lysis syndrome differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Tumor lysis syndrome must be differentiated from other diseases that cause hyperuricemia, hyperkalemia, and hyperphosphatemia, such as acute kidney injury. The common conditions are hereditary hyperuricemia, Insulin resistance, Hypertension, Obesity, Gout, Alcoholism and renal insufficiency. Patients taking ACE inhibitor, NSAIDs and Antibiotics such as trimethoprim are more prone to hyperkalemia. Hyperphosphatemia is usually seen in Acute kidney injury, Hypoparathyroidism, vitamin D supplementation and also in sarcoidos.

Differentiating tumor lysis syndrome from other Diseases

Tumor lysis syndrome must be differentiated from other diseases that cause electrolytes disturbance.[1]

  • Transcellular phosphate shifts:

References

  1. Wilson FP, Berns JS (2014). "Tumor lysis syndrome: new challenges and recent advances". Adv Chronic Kidney Dis. 21 (1): 18–26. doi:10.1053/j.ackd.2013.07.001. PMC 4017246. PMID 24359983.
  2. 2.0 2.1 2.2 Wikipedia.https://en.wikipedia.org/wiki/Hyperuricemia

Template:WH Template:WS